Forward P/S Multiple: NeuroOne Medical Technologies Corporation (NMTC)
NeuroOne Medical Technologies (NMTC) develops thin electrodes for neurosurgery, serving the B2B sector and optimizing component inventories to eliminate disruptions. This chart, provided by GURU.Markets, illustrates the company's projected P/S valuation dynamics, while the 0.70 level captures the latest values. Revenues are based on equipment supplies to neurological centers for the diagnosis of epilepsy and Parkinson's disease.
Summary analytical data breakdowns for NeuroOne Medical Technologies Corp. (NMTC)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital NeuroOne Medical Technologies|NMTC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital NeuroOne Medical Technologies|NMTC - Company Aggregate Debts|Debt to Book Capitalization Ratio NeuroOne Medical Technologies Corp.|NMTC - Company Long-Term Debt|Company Current Liabilities NeuroOne Medical Technologies|Quick Ratio n1mtc.com
- financial results and valuation multiples details:
NMTC - Company Net Income|Expected Profit NeuroOne Medical Technologies|NMTC - Market Cap to Net Income Ratio|Projected Price to Earnings NeuroOne Corp|NMTC - PEG Multiple|EV/EBITDA Multiple NeuroOne Medical Technologies Corp.|NMTC - Operating income before deduction of amortization|Earnings per share for the last twelve months NeuroOne Medical Technologies|NMTC - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months n1mtc.com|NMTC - Net earnings per share growth this year|Earnings growth forecast for next year NeuroOne Medical Technologies
- sales and revenue indicators:
Fundamental company analysis:NMTC (NeuroOne Medical Technologies Corporation)
The commercialization of thin-film electrodes by NeuroOne Medical Technologies (NMTC) activates operating leverage, which, given high R&D expenses, shifts the valuation focus toward revenue growth rates. The expected P/S ratio correlates current market capitalization with projected annual turnover, allowing investors to assess the premium paid for future business scale and track market expectations through the price action of this chart.
Who NeuroOne Medical Technologies competes with
Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Orthofix International - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bioventus Global BVS|OrthoPediatrics Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio treace.com TMCI|Strata Critical Medical (SRTA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CARL (Carlsmed, Inc.)|Price-to-Projected Revenue Ratio RxSight Corp|Forward Price-to-Revenue Multiple ClearPoint (CLPT)|Forward P/S Multiple STXS|STIM - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Sight Sciences SGHT|OBIO: Market Cap to Projected Revenue|ANIK: Forward Price-to-Revenue Multiple|InspireMD Inc. - Price to Expected Revenue Ratio|zhjmedical.com (ZJYL) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue VANI|XTNT (Xtant Medical Holdings, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Modular Med MODD|Forward Price-to-Revenue Multiple MYO (Myomo, Inc)|Forward P/S Multiple Envoy Medical Inc (COCH)|Price-to-Projected Revenue Ratio Vivos Therapeutics VVOS|Forward Price to Sales NVNO|SINT - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Autonomix Medical (AMIX)|Price-to-Projected Revenue Ratio INVO Fertility Inc|Market Cap to Projected Revenue BBLG (bonebiologics.com)|Forward P/S Multiple AXNX|BIOL - Market Cap to Future Revenue Ratio|Dynatronics - Forward Price-to-Revenue Multiple|Forward Price to Sales FNA|INVO - Price-to-Projected Revenue Ratio
